 WTHI [1] |
Amylin Seeks FDA Approval on Extended Byetta Treatment [2]
Wall Street Journal – David Benoit [3] The company submitted exenatide, an injection treatment fortype 2 diabetes, after it showed in late March it had the ability to control blood sugar better than current tablet forms ofdiabetesdrugs. The treatment, which is co-developed with Eli Lilly… Exenatide Once Weekly New Drug Application Submitted to FDA for… [4]PR Newswire (press release) Lilly, Amylin, Alkermes file for FDA drug approval [5]MarketWatch Amylin, Lilly Seek FDA Approval For First-Ever Once-Weekly… [6]Trading Markets (press release) San Diego Business Journal [7] –MSN Money [8] all 199 news articles [9] |